Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Earnings for Medpace Holdings, Inc. (MEDP)
Earnings in 2023 (TTM): $335.68 M
According to Medpace Holdings, Inc.'s latest financial reports the company's current earnings (TTM) are $335.68 M. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Medpace Holdings, Inc.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $335.68 M | $282.81 M |
| 2022 | $282.86 M | $245.21 M |
| 2021 | $201.85 M | $181.39 M |
| 2020 | $168.53 M | $144.93 M |
| 2019 | $124.83 M | $100.16 M |
| 2018 | $93.95 M | $72.89 M |
| 2017 | $56.95 M | $39.03 M |
| 2016 | $21.96 M | $13.39 M |
| 2015 | $-7,830,000 | $-8,673,000 |
| 2014 | $-21,261,000 | $-15,572,000 |
| 2013 | $39.15 M | $24.84 M |